BioHarvest Sciences (BHST) Stock Price, News & Analysis

Company Overview

BioHarvest Sciences Inc. is a biotech firm. It focused on leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions, within business verticals nutraceutical health and wellness products such as dietary supplements and development of plant cell-based Active Pharmaceutical Ingredients which focus on specific medical indications. BioHarvest Sciences Inc. is based in Vancouver, Canada.

Key Stats

• Today's Range: $7.40 to $7.69
• 50-Day Range: $6.10 to $7.85
• 52-Week Range: $4.66 to $7.99
• Volume: 4,569 shs
• Average Volume: 14,945 shs
• Market Capitalization: $121.71 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $13.67
• Consensus Rating: Buy

BHST Stock Analysis - Frequently Asked Questions

How have BHST shares performed this year?

BioHarvest Sciences' stock was trading at $6.18 at the beginning of 2025. Since then, BHST stock has increased by 19.9% and is now trading at $7.41.

How were BioHarvest Sciences' earnings last quarter?

BioHarvest Sciences Inc. (NASDAQ:BHST) released its quarterly earnings data on Thursday, May, 15th. The company reported ($0.13) EPS for the quarter, beating analysts' consensus estimates of ($0.15) by $0.02. The business earned $7.64 million during the quarter, compared to analysts' expectations of $8.93 million. BioHarvest Sciences had a negative trailing twelve-month return on equity of 307.04% and a negative net margin of 31.30%.
Read the conference call transcript.

Who are BioHarvest Sciences' major shareholders?

Top institutional shareholders of BioHarvest Sciences include Magnus Financial Group LLC (0.43%) and True North Advisors LLC (0.13%).

How do I buy shares of BioHarvest Sciences?

Shares of BHST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Last Earnings: 5/15/2025
• Today: 7/30/2025
• Next Earnings (Estimated): 8/14/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED - BIOMED/GENE
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:BHST
• Previous Symbol: NASDAQ:BHST
• CIK: 1723464
• Web: bioharvest.com
• Phone: 646-863-2177
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Price Target and Rating

• Average Price Target for BioHarvest Sciences: $13.67
• High Price Target: $15.00
• Low Price Target: $12.00
• Potential Upside/Downside: +84.4%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 3 Analysts

Profitability

• EPS (Trailing Twelve Months): ($0.50)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$12.91 million
• Net Margins: -31.30%
• Pretax Margin: -31.13%
• Return on Equity: -307.04%
• Return on Assets: -33.21%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.51
• Quick Ratio: 0.30

Sales & Book Value

• Annual Sales: $27.70 million
• Price / Sales: 4.39
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.08 per share
• Price / Book: 92.63

Miscellaneous

• Outstanding Shares: 16,425,000
• Free Float: N/A
• Market Cap: $121.71 million
• Optionable: N/A
• Beta: 0.65